Condition

Arteriovenous Fistula

ClinicalTrials.gov condition label

Clinical trials4

Recruiting1

Common interventions4

Lead sponsors shown4

Clinical trials

4 shown

Cera™ Vascular Plug System Post-Market Clinical Follow-UpNCT06099015 · 2024-06-21

RECRUITING

Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous FistulaNCT06199609 · 2022-09-01

COMPLETED

Vascular Protective Effect of Rosuvastatin in Arteriovenous FistulaNCT01863914 · 2012-11-01

COMPLETED

Etiologies, Investigations and Outcomes of Patients Presenting With HemoptysisNCT02913365 · 2012-10-01

UNKNOWN

Common interventions

AVFPROCEDURE1Cera™ Vascular Plug SystemDEVICE1Hemodialysis pathwayPROCEDURE1RosuvastatinDRUG1

Leading sponsors

Haiyan Wang1Lifetech Scientific (Shenzhen) Co., Ltd.1National Cheng-Kung University Hospital1Université de Sherbrooke1

Trial status mix

COMPLETED2

RECRUITING1

UNKNOWN1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.